The Brain Innovation Days are fast approaching, taking place in Brussels on 11-12 October 2022.

Read the latest reports from EAN Clinical Fellowship participants on their experiences in Innsbruck and London.

The EAN Guideline Production Group has developed a template for EAN guideline protocols, to facilitate production of high quality guidelines.

26th Conference of the European Society of Neurosonology and Cerebral Hemodynamics (ESNCH) October 14-16, 2022 Neurosonology 2022 will mark the return of fully presential meetings to the main worldwide event in Neurosonology, representing a unique opportunity to share knowledge. The… Continue Reading

Dr. Martin Rakusa speaks to Profs. Kristian Steen Frederiksen and Flavio Nobili, co-chairs of the EAN Scientific Panel on Dementia and Cognitive Disorders.

In summer 2022 EAN introduced a new membership benefit for Student Members: the option to join the EAN Scientific & Coordinating Panels.

Our highlighted selection of recent Covid-related case series or case reports from the scientific press for September 2022.

Our editors' pick of recent Covid-related cross-sectional case control studies from the scientific press for September 2022.

With relatively few chances for EAN staff and members to meet in person, we decided to use this platform to present the team behind the scenes. This time it's Julia, Acting Head of the Scientific Dept, and Sara from the Industry Department.

This week, the European Brain Council responded to the European Commission’s Call for Proposals on 2022 Thematic Networks, which invites health stakeholders to submit proposals for a new cycle of Thematic Networks, organised under the framework of the EU Health… Continue Reading

A joint session between the International Parkinson and Movement Disorder Society and the EAN will be held on 16 September, during the MDS Congress.

For the 9th Annual Congress of the European Academy of Neurology on July 1-4 we are heading to the grand and beautiful city of Budapest, Hungary, right in the heart of Europe.

New EAN Education Committee Chair, Irena Rektorova, introduces herself with an overview of recent and upcoming EAN educational initiatives.

This month we have selected two phase-2 trials investigating α-synuclein-binding antibodies as potential disease-modifying treatment of Parkinson’s disease.

Our authors of the month for September conclude that people with Parkinson's Disease and parkinsonism showed a higher risk of SARS-CoV-2 infection throughout the first 15 months of the pandemic.